Gilead Sciences | Los Gastos De Explotación


Operating Expenses Cambio
Abbvie ABBV:US $ 11288M 2467M
Acorda Therapeutics ACOR:US $ 44.97M 5.73M
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
ALKERMES ALKS:US 310.68M 5.55M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amgen AMGN:US $ 4.42B 680M
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Coherus Biosciences CHRS:US $ 104.16M 43.1M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Gilead Sciences GILD:US $ 4231M 2162M
Glaxosmithkline GSK:US 5.85B 1.13B
GlaxoSmithKline GSK:LN 5.85B 1.13B
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
Johnson & Johnson JNJ:US $ 18.18B 616M
Merk MRK:US $ 9666M 666M
Moderna Inc MRNA:US 2.3B 463M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Novartis NOVN:VX 10.86B 895M
Pfizer PFE:US $ 15640M 148M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Puma Biotechnology PBYI:US $ 47.52M 1.01M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Teva Pharmaceutical Industries TEVA:US 4.74B 361M
United Therapeutics UTHR:US $ 265.1M 89.5M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
YTE INCY:US $ 656.97M 40.27M



Gilead Sciences Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2022.